Insiders · Profile

Graham G. Walmsley

Director at Olema Pharmaceuticals · Director at ALX ONCOLOGY. Filing since 21 Jul 2020. CIK 0001777517

Company
Date
Role
Action
Shares
Amount
Of holding
17 Dec 2024
Director
Sold at will
700,761
$4.73M
33.2%
17 Dec 2024
Director
Sold at will
700,761
$4.73M
100%
4 Jun 2024
Director
Sold at will
1,175,000
$17.45M
62.6%
5 Dec 2023
Director
Bought
131,870
$1.87M
7.9%
12 Sep 2023
Director
Bought
508,130
$5.00M
43.8%
14 Dec 2020
Director
Bought
20,000
$1.52M
2.1%
23 Nov 2020
Director
Bought
1,160,000
$22.04M
opened
21 Jul 2020
Director
Bought
975,000
$18.53M
opened
8 decisions on file.